Cargando…
Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
BACKGROUND: The underlying mechanism of brain glucose hypometabolism, an invariant neurodegenerative feature that tightly correlates with cognitive impairment and disease progression of Alzheimer’s disease (AD), remains elusive. METHODS: Positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-gl...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831864/ https://www.ncbi.nlm.nih.gov/pubmed/29490669 http://dx.doi.org/10.1186/s13195-018-0354-2 |
_version_ | 1783303215869067264 |
---|---|
author | Sang, Shaoming Pan, Xiaoli Chen, Zhichun Zeng, Fan Pan, Shumei Liu, Huimin Jin, Lirong Fei, Guoqiang Wang, Changpeng Ren, Shuhua Jiao, Fangyang Bao, Weiqi Zhou, Weiyan Guan, Yihui Zhang, Yiqiu Shi, Hongcheng Wang, Yanjiang Yu, Xiang Wang, Yun Zhong, Chunjiu |
author_facet | Sang, Shaoming Pan, Xiaoli Chen, Zhichun Zeng, Fan Pan, Shumei Liu, Huimin Jin, Lirong Fei, Guoqiang Wang, Changpeng Ren, Shuhua Jiao, Fangyang Bao, Weiqi Zhou, Weiyan Guan, Yihui Zhang, Yiqiu Shi, Hongcheng Wang, Yanjiang Yu, Xiang Wang, Yun Zhong, Chunjiu |
author_sort | Sang, Shaoming |
collection | PubMed |
description | BACKGROUND: The underlying mechanism of brain glucose hypometabolism, an invariant neurodegenerative feature that tightly correlates with cognitive impairment and disease progression of Alzheimer’s disease (AD), remains elusive. METHODS: Positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG-PET) was used to evaluate brain glucose metabolism, presented as the rate of 2-[(18)F]fluoro-2-deoxy-d-glucose standardized uptake value ratio (FDG SUVR) in patients with AD or control subjects and in mice with or without thiamine deficiency induced by a thiamine-deprived diet. Brain amyloid-β (Aβ) deposition in patients with clinically diagnosed AD was quantified by performing assays using (11)C-Pittsburgh compound B PET. The levels of thiamine metabolites in blood samples of patients with AD and control subjects, as well as in blood and brain samples of mice, were detected by high-performance liquid chromatography with fluorescence detection. RESULTS: FDG SUVRs in frontal, temporal, and parietal cortices of patients with AD were closely correlated with the levels of blood thiamine diphosphate (TDP) and cognitive abilities, but not with brain Aβ deposition. Mice on a thiamine-deprived diet manifested a significant decline of FDG SUVRs in multiple brain regions as compared with those in control mice, with magnitudes highly correlating with both brain and blood TDP levels. There were no significant differences in the changes of FDG SUVRs in observed brain regions between amyloid precursor protein/presenilin-1 and wild-type mice following thiamine deficiency. CONCLUSIONS: We demonstrate, for the first time to our knowledge, in vivo that TDP reduction strongly correlates with brain glucose hypometabolism, whereas amyloid deposition does not. Our study provides new insight into the pathogenesis and therapeutic strategy for AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0354-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5831864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58318642018-03-05 Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not Sang, Shaoming Pan, Xiaoli Chen, Zhichun Zeng, Fan Pan, Shumei Liu, Huimin Jin, Lirong Fei, Guoqiang Wang, Changpeng Ren, Shuhua Jiao, Fangyang Bao, Weiqi Zhou, Weiyan Guan, Yihui Zhang, Yiqiu Shi, Hongcheng Wang, Yanjiang Yu, Xiang Wang, Yun Zhong, Chunjiu Alzheimers Res Ther Research BACKGROUND: The underlying mechanism of brain glucose hypometabolism, an invariant neurodegenerative feature that tightly correlates with cognitive impairment and disease progression of Alzheimer’s disease (AD), remains elusive. METHODS: Positron emission tomography with 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG-PET) was used to evaluate brain glucose metabolism, presented as the rate of 2-[(18)F]fluoro-2-deoxy-d-glucose standardized uptake value ratio (FDG SUVR) in patients with AD or control subjects and in mice with or without thiamine deficiency induced by a thiamine-deprived diet. Brain amyloid-β (Aβ) deposition in patients with clinically diagnosed AD was quantified by performing assays using (11)C-Pittsburgh compound B PET. The levels of thiamine metabolites in blood samples of patients with AD and control subjects, as well as in blood and brain samples of mice, were detected by high-performance liquid chromatography with fluorescence detection. RESULTS: FDG SUVRs in frontal, temporal, and parietal cortices of patients with AD were closely correlated with the levels of blood thiamine diphosphate (TDP) and cognitive abilities, but not with brain Aβ deposition. Mice on a thiamine-deprived diet manifested a significant decline of FDG SUVRs in multiple brain regions as compared with those in control mice, with magnitudes highly correlating with both brain and blood TDP levels. There were no significant differences in the changes of FDG SUVRs in observed brain regions between amyloid precursor protein/presenilin-1 and wild-type mice following thiamine deficiency. CONCLUSIONS: We demonstrate, for the first time to our knowledge, in vivo that TDP reduction strongly correlates with brain glucose hypometabolism, whereas amyloid deposition does not. Our study provides new insight into the pathogenesis and therapeutic strategy for AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0354-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-01 /pmc/articles/PMC5831864/ /pubmed/29490669 http://dx.doi.org/10.1186/s13195-018-0354-2 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Sang, Shaoming Pan, Xiaoli Chen, Zhichun Zeng, Fan Pan, Shumei Liu, Huimin Jin, Lirong Fei, Guoqiang Wang, Changpeng Ren, Shuhua Jiao, Fangyang Bao, Weiqi Zhou, Weiyan Guan, Yihui Zhang, Yiqiu Shi, Hongcheng Wang, Yanjiang Yu, Xiang Wang, Yun Zhong, Chunjiu Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not |
title | Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not |
title_full | Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not |
title_fullStr | Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not |
title_full_unstemmed | Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not |
title_short | Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not |
title_sort | thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in alzheimer’s disease, whereas amyloid deposition does not |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831864/ https://www.ncbi.nlm.nih.gov/pubmed/29490669 http://dx.doi.org/10.1186/s13195-018-0354-2 |
work_keys_str_mv | AT sangshaoming thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT panxiaoli thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT chenzhichun thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT zengfan thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT panshumei thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT liuhuimin thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT jinlirong thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT feiguoqiang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT wangchangpeng thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT renshuhua thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT jiaofangyang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT baoweiqi thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT zhouweiyan thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT guanyihui thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT zhangyiqiu thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT shihongcheng thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT wangyanjiang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT yuxiang thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT wangyun thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot AT zhongchunjiu thiaminediphosphatereductionstronglycorrelateswithbrainglucosehypometabolisminalzheimersdiseasewhereasamyloiddepositiondoesnot |